Dexamethasone Injection and Cannabis: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Cannabis
No brand names on recordDexamethasone Injection
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Reduced cannabis exposure
Interaction Deep Dive
Delta-9-tetrahydrocannabinol (THC), which is found in cannabis products, is a CYP3A4 substrate; the primary psychoactive metabolite of THC (11-hydroxy-THC) is also metabolized by CYP3A41. Coadministration of cannabis with a CYP3A4 inducer may decrease exposure and efficacy of cannabis. If coadministration is required, consider increasing the cannabis dosage. Expect the clinical significance of cannabis drug interactions to vary due to the wide variability of cannabis products (eg, potencies, THC and cannabidiol [CBD] ratios, dosage ranges, and administration routes) and populations using cannabinoids 2. If concomitant use is necessary, adjust dosage of CYP3A inducer, and monitor drug levels if possible 3.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of delta-9-tetrahydrocannabinol (THC)
Literature reports
1 report — tap to read
a) In an open-label crossover study of healthy male subjects (N=36), coadministration of a single dose of delta-9-tetrahydrocannabinol (THC)/cannabidiol(CBD) oromucosal spray and rifampicin (a strong CYP3A4 inducer) compared with a single dose of THC/CBD spray alone decreased the Cmax and AUC(0 to infinity) of THC (1.88 vs 2.94 nanograms[ng]/mL and 7.53 vs 9.86 ng x hr/mL, respectively). Additionally, the Cmax and AUC of the primary psychoactive metabolite of THC, 11-hydroxy-THC, decreased with coadministration (0.45 vs 3.38 ng/mL and 2.78 vs 21.59 ng x hr/mL, respectively). Subjects were divided into 3 groups and received a single dose THC/CBD spray (4 sprays; total dose, 10.8 mg/10 mg) with either rifampicin 600 mg, ketoconazole 400 mg, or omeprazole 40 mg in various sequences throughout the study. This study demonstrated that both THC and 11-hydroxy-THC are substrates of CYP3A4 1.
Common questions
Can I take Dexamethasone Injection and Cannabis together?
Reduced cannabis exposure Always confirm with your pharmacist or prescriber before making any change.
How serious is the Dexamethasone Injection and Cannabis interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Dexamethasone Injection or Cannabis need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (3)
- Stott C, White L, Wright S, et al: A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of rifampicin, ketoconazole, and omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers. Springerplus 2013; 2(1):236. PubMed
- Page RL II, Allen LA, Kloner RA, et al: Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2020; 142(10):e131-e152. PubMed
- Caicedo DA, Perez-Mana C, Farre M, et al: An overview of the potential for pharmacokinetic interactions between drugs and cannabis products in humans. Pharmaceutics 2025; 17(3):319. DOI
Keep reading about Cannabis
Keep reading about Dexamethasone Injection
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist